Actient Pharmaceuticals has acquired Timm Medical Technologies, a provider in products and services for the diagnosis and treatment of urological disorders, primarily in the area of erectile dysfunction.
The acquisition of Timm Medical is consistent with Actient’s strategic focus in urology and Actient is able to offer pharmaceutical, and medical device and diagnostic solutions to the urology community.
Actient CEO Ed Fiorentino said they look forward to combine the companies and expanding their efforts in providing urology products and services that improve patient outcomes.
Timm Medical president David Talen said they believe that Actient will help enhance their position as a valued resource for urologists and patients.